Sean Murphy Med Tech Acquisition Corp (MTACW) insider trading activity

MTACW Quotes by TradingView

Sean Murphy is Chief Manuf, Strategy&Bus Dev. of MedTech Acquisition Corp. Currently has a direct ownership of 79,105 shares of MTACW, which is worth approximately $17,403. The most recent transaction as insider was on Feb 18, 2025, when has been sold 15,817 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 79.1K
55.76% 3M change
55.76% 12M change
Total Value Held $17,403

Sean Murphy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 18 2025
BUY
Grant, award, or other acquisition
-
15,817 Added 16.66%
79,105 Common Stock
Jan 27 2025
BUY
Grant, award, or other acquisition
-
12,500 Added 16.49%
63,288 Common Stock
Feb 12 2024
BUY
Grant, award, or other acquisition
-
34,144 Added 40.2%
50,788 Common Stock

Also insider at

RDUS
Radius Health, Inc. Healthcare
Director
SM

Sean Murphy

Chief Manuf, Strategy&Bus Dev.
Boston, MA

Track Institutional and Insider Activities on MTACW

Follow MedTech Acquisition Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MTACW shares.

Notify only if

Insider Trading

Get notified when an Med Tech Acquisition Corp insider buys or sells MTACW shares.

Notify only if

News

Receive news related to MedTech Acquisition Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MTACW